Welcure Drugs and Pharmaceuticals Limited (BOM:524661)

BOM:524661 Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1.24	1.28	0.22	0.01	0.66	0.47
Cash & Short-Term Investments	1.24	1.28	0.22	0.01	0.66	0.47
Cash Growth	-45.55%	493.98%	1700.00%	-98.18%	39.09%	795.43%
Accounts Receivable	3,845	189.5	-	-	-	-
Receivables	3,845	189.5	-	-	-	-
Inventory	1,435	1,435	-	-	-	-
Other Current Assets	199.12	195.39	0.1	0.05	-	-
Total Current Assets	5,480	1,821	0.32	0.06	0.66	0.47
Property, Plant & Equipment	0.21	0.3	0.21	0.57	-	-
Long-Term Investments	-	-	-	1.65	-	-
Other Long-Term Assets	0.89	0.77	0.31	0.31	0.31	0.26
Total Assets	6,329	2,670	13.71	15.29	0.97	0.73
Accounts Payable	3,257	28.98	-	-	-	-
Accrued Expenses	-	0.61	0.11	0.14	0.04	0.04
Current Income Taxes Payable	-	6.1	-	-	-	-
Other Current Liabilities	496.35	377	0.2	-	-	0
Total Current Liabilities	3,754	412.69	0.31	0.14	0.04	0.04
Long-Term Debt	1,232	1,232	-	-	-	-
Other Long-Term Liabilities	-	-	-0	0	-	-
Total Liabilities	4,986	1,645	0.31	0.14	0.04	0.04
Common Stock	1,124	1,124	134.39	134.39	121.19	121.19
Retained Earnings	218.76	-99.29	-120.99	-119.24	-120.26	-120.49
Comprehensive Income & Other	-	-	-	-0	-	-
Shareholders' Equity	1,343	1,025	13.41	15.15	0.93	0.69
Total Liabilities & Equity	6,329	2,670	13.71	15.29	0.97	0.73
Total Debt	1,232	1,232	-	-	-	-
Net Cash (Debt)	-1,231	-1,231	0.22	0.01	0.66	0.47
Net Cash Growth	-	-	1700.00%	-98.18%	39.09%	795.43%
Net Cash Per Share	-1.46	-1.43	0.00	0.00	0.00	0.00
Filing Date Shares Outstanding	1,231	1,238	148.63	148.63	148.63	147.41
Total Common Shares Outstanding	1,231	1,238	148.63	148.63	148.63	147.41
Working Capital	1,727	1,409	0.01	-0.08	0.62	0.44
Book Value Per Share	1.09	0.83	0.09	0.10	0.01	0.00
Tangible Book Value	1,343	1,025	13.41	15.15	0.93	0.69
Tangible Book Value Per Share	1.09	0.83	0.09	0.10	0.01	0.00
Machinery	-	0.77	0.6	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.